Washington state-based Stemilt Growers has introduced Rave, an apple developed at and licensed from the University of Minnesota.
A U of M biotech startup filed last month to raise up to $50 million in an initial public offering.
A biotech startup based on U of M anticancer research aims to begin clinical trials for a new immunological drug that could fight brain cancer.
The U of M Venture Center’s first startup company, which provides technology and services to insurers for use in helping patients manage their prescription drugs, has been acquired.
A biotechnology company based in Eden Prairie, MN, is using University of Minnesota research to help shorten the list of patients awaiting organ transplants.
A new apple variety called Rave, developed at the U of M, is about to reach the market for the first time.
U of M startup Calyxt Inc. aims to raise up to $50 million in investment through an initial public offering.
A Kickstarter funding effort by U of M startup Turing Tumble has taken off, bringing the educational computing game past its original funding goal.
St. Paul-based Summit Medical, which has developed a medical device to help mend broken jaws based on U of M technology, has received regulatory clearance to begin selling the device as a product.
The U of M’s efforts to move technology beyond the lab and into the market has been ranked among the best in the nation among public universities.